Seqanswers Leaderboard Ad
Collapse
Announcement
Collapse
No announcement yet.
X
-
Transferring patient's genetic testing data to the cloud: 5 myths
Full article
We often get the question: how safe is it to transfer patient’s genomic data to the cloud? By this most people refer to the transfer of their NGS-based patient data to external web-based services (e.g. Illumina Basespace) that run on the public cloud of other third-party providers (e.g. Amazon AWS).
Of course, patient genetic data security should be a top priority. New sequencing technologies create large data volumes for each patient, and often small labs and hospitals assume that they cannot cope with the required increase in computational resources, leaving the cloud the only option. After all, cloud-based solutions are good for cases where varying amounts of data must be processed flexibly. But it is also true that a patient’s genetic testing data has a different privacy value compared to for example videos, music, images or other large data. Genetic testing data contains highly personal information, including health, behavioural and biometric information, and is an even more unique marker than a fingerprint. A DNA data breach is much worse than a credit card breach.
With that in mind, let us address the following misconceptions and myths we often hear. ...read more
Last edited by ecSeq Bioinformatics; 03-03-2020, 10:44 PM.
Latest Articles
Collapse
-
by seqadmin
Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...-
Channel: Articles
04-04-2024, 04:25 PM -
-
by seqadmin
Despite advancements in sequencing platforms and related sample preparation technologies, certain sample types continue to present significant challenges that can compromise sequencing results. Pedro Echave, Senior Manager of the Global Business Segment at Revvity, explained that the success of a sequencing experiment ultimately depends on the amount and integrity of the nucleic acid template (RNA or DNA) obtained from a sample. “The better the quality of the nucleic acid isolated...-
Channel: Articles
03-22-2024, 06:39 AM -
ad_right_rmr
Collapse
News
Collapse
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Started by seqadmin, 04-11-2024, 12:08 PM
|
0 responses
30 views
0 likes
|
Last Post
by seqadmin
04-11-2024, 12:08 PM
|
||
Started by seqadmin, 04-10-2024, 10:19 PM
|
0 responses
32 views
0 likes
|
Last Post
by seqadmin
04-10-2024, 10:19 PM
|
||
Started by seqadmin, 04-10-2024, 09:21 AM
|
0 responses
28 views
0 likes
|
Last Post
by seqadmin
04-10-2024, 09:21 AM
|
||
Started by seqadmin, 04-04-2024, 09:00 AM
|
0 responses
53 views
0 likes
|
Last Post
by seqadmin
04-04-2024, 09:00 AM
|
Leave a comment: